Helicobacter pylori eradication with high-dose proton pump inhibitor-amoxicillin dual therapy: A systematic review and meta-analysis

幽门螺杆菌 阿莫西林 质子抑制剂泵 荟萃分析 医学 内科学 胃肠病学 微生物学 抗生素 生物
作者
Jia-Ai Yeh,Huei‐Kai Huang,Ai-Li Chou,Hwai‐Jeng Lin,Chun‐Lung Feng,Chia‐Jung Kuo,Chih‐Ho Lai
出处
期刊:International Journal of Antimicrobial Agents [Elsevier BV]
卷期号:63 (6): 107159-107159 被引量:4
标识
DOI:10.1016/j.ijantimicag.2024.107159
摘要

Resistance of Helicobacter pylori to many antibiotics, which lowers the efficacy of eradication therapy, is increasingly prevalent. High-dose proton pump inhibitor (PPI)-amoxicillin dual therapy (HDDT) has been used for H. pylori eradication for years, and resistance to amoxicillin is relatively rare. Although many studies have compared the eradication rate of HDDT with that of guideline therapies, the reported efficacy of HDDT varies greatly and is inconsistent. This study investigated the eradication rate and adverse effects of HDDT compared with the guidelines at the time of the study. Several open public databases, including Cochrane, EMBASE, PubMed, and MEDLINE, were searched. The results of the current literature on the eradication and adverse event rates of HDDT compared with the latest recommended first-line therapies were analyzed. Notably, 14 out of the 16 included studies were conducted in Asian regions. The eradication rate of HDDT was lower but not significantly different from those of control therapies (odds ratio [OR] = 0.92, 95% confidence interval [CI] = 0.67–1.26) in the intent-to-treat (ITT) analysis. A similar trend was observed in the per-protocol (PP) analysis (OR = 0.88, 95% CI = 0.47–1.63). Notably, the adverse effect risk in HDDT was significantly lower than in other therapies (I2 = 67.75%, OR = 0.42, 95% CI = 0.33–0.54, p = 0.00004). When the eradication rate of the control group was lower than 81%, HDDT was significantly better than control therapies (OR = 2.44, 95% CI = 1.23–4.84). HDDT used four times a day for 14 days showed better efficacy and safety than the guideline treatments for H. pylori infection in areas with high antimicrobial resistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科目三应助科研通管家采纳,获得10
刚刚
wanci应助科研通管家采纳,获得10
刚刚
斯文败类应助科研通管家采纳,获得10
刚刚
田様应助科研通管家采纳,获得10
刚刚
Orange应助科研通管家采纳,获得10
刚刚
刚刚
fang应助科研通管家采纳,获得10
刚刚
共享精神应助科研通管家采纳,获得10
刚刚
山野村夫应助科研通管家采纳,获得10
1秒前
zz应助科研通管家采纳,获得10
1秒前
Singularity应助科研通管家采纳,获得10
1秒前
Singularity应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
1秒前
赘婿应助nkmenghan采纳,获得10
1秒前
芝麻福福完成签到,获得积分10
1秒前
快乐枫发布了新的文献求助10
1秒前
blue发布了新的文献求助10
2秒前
晚灯君完成签到 ,获得积分10
3秒前
UU发布了新的文献求助10
3秒前
lrll完成签到,获得积分10
5秒前
5秒前
lele完成签到,获得积分10
5秒前
hhh发布了新的文献求助10
8秒前
我要看文献完成签到 ,获得积分10
8秒前
wdd完成签到 ,获得积分10
10秒前
李爱国应助开心薯片采纳,获得10
11秒前
12秒前
Z_yiming发布了新的文献求助10
12秒前
爱吃草莓和菠萝的吕可爱完成签到,获得积分10
14秒前
缥缈一刀发布了新的文献求助10
16秒前
小地蛋完成签到 ,获得积分10
17秒前
感谢大哥的帮助完成签到 ,获得积分10
17秒前
614521完成签到,获得积分10
19秒前
111完成签到,获得积分10
20秒前
王先生完成签到 ,获得积分10
20秒前
21秒前
殊荣完成签到,获得积分10
22秒前
JAMA兜里揣完成签到,获得积分10
22秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029